Skip to main content
Home
  • About Us
    • About Us
    • Mission & Values
    • Leadership
    • News
    • Careers
    • Partnerships
    • Support
    • Achievements
  • For Researchers
    • Clinical Trials
      • Allergy & Asthma
      • Autoimmune Disease
      • Transplantation
      • Type 1 Diabetes
    • Core Facilities
    • Lab Protocols
      • ITN Protocols
      • T1D Preclinical Consortium
    • Policies
      • Publications Policy
    • Proposals
      • Submit Proposal
      • Current RFPs
      • Past RFPs
    • Publications
    • TrialShare
    • Strategic Plans
      • Allergy
      • Autoimmune Disease
        • Type 1 Diabetes
      • Transplantation
  • For Patients
    • Allergy & Asthma
    • Autoimmune Disease
    • Transplantation
      • Kidney
      • Liver
    • Type 1 Diabetes
    • Clinical Trial Info
  • TrialShare
  • Contact
    • Contact Us
      • BRI - Seattle Office
      • UCSF - San Francisco Office
    • Media Inquiries
Home

Secondary links

  • Home
  • TrialShare
  • Member Portal
  • About Us
    • About Us
    • Mission & Values
    • Leadership
    • News
    • Careers
    • Partnerships
    • Support
    • Achievements
  • For Researchers
    • Clinical Trials
    • Core Facilities
    • Lab Protocols
    • Policies
    • Proposals
    • Publications
    • TrialShare
    • Strategic Plans
  • For Patients
    • Allergy & Asthma
    • Autoimmune Disease
    • Transplantation
    • Type 1 Diabetes
    • Clinical Trial Info
  • TrialShare
  • Contact
    • Contact Us
    • Media Inquiries

Primary links

  • About Us
  • Mission & Values
  • Leadership
  • News
  • Careers
  • Partnerships
  • Support
  • Achievements

ITN Peanut Allergy Prevention Study Highlighted in the Wall Street Journal

March 06, 2013 --

A March 6, 2013 Wall Street Journal article, “Food Allergy Advice for Kids: Don’t Delay Peanuts, Eggs”, discusses the changing landscape surrounding food allergy prevention, citing the Immune Tolerance Network’s (ITN’s) LEAP study as a pivotal effort in determining whether the early introduction of allergenic foods may actually help prevent the development of allergies. The article points out that the increasing prevalence of food allergies in children in the US and other Western countries calls into question the guidelines from the American Academy of Pediatrics that recommend avoiding the introduction of certain allergenic foods (milk, eggs, peanuts, shellfish, tree nuts, and fish) before a certain age as a strategy to avoid future allergies.

In the ITN’s LEAP study, “Promoting Tolerance to Peanut in High-Risk Children” led by Gideon Lack, MD (King’s College London) 640 infants have been randomized to either receive peanut or placebo, and will be followed to the age of five to compare the allergy rates in each group. Results are expected at the end of 2015, and the Wall Street Journal article highlights the hope that this ITN study will provide critical data needed for developing future recommendations about food allergy prevention.

The Immune Tolerance Network and is sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

National Institute of Allergy and Infectious Diseases

Footer

  • Home
  • Sponsors
  • Careers
  • Contact
  • Search

© 2021 Immune Tolerance Network

  • Privacy
  • Terms of Use
  • Accessibility